Dx Deals: Labcorp and BioReference Health Agree on $225m Sale of Some Assets
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health
Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health